Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression

Autoimmunity Reviews
Tania ColasantiElena Ortona

Abstract

Growing evidence suggests that autoantibodies specific to distinct molecular antigens are present in sera or cerebrospinal fluids from patients with Alzheimer's disease (AD). They could have a protective (i.e., anti-β-amyloid) or a pathogenetic role (i.e., anti-GM1 or anti-ATP synthase) but, in any case, they might be considered as useful diagnostic or prognostic markers of the disease. In this review, we briefly summarize the autoantibodies known to be detectable in patients with AD and we discuss their potential role in the pathogenesis of the disease, as well as their potential use as peripheral blood biomarkers.

References

May 7, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Claus W HeizmannBeat W Schäfer
Dec 20, 2002·Nature·Howard L Weiner, Dennis J Selkoe
Aug 12, 2003·Brain Research Bulletin·A PetzoldE J Thompson
Sep 21, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·R C DodelW H Oertel
Feb 14, 2006·Current Alzheimer Research·John Hardy
Sep 6, 2007·Annals of the New York Academy of Sciences·John A McIntyreSteven T DeKosky
May 30, 2008·American Journal of Alzheimer's Disease and Other Dementias·Eleni HatzifilippouStavros J Baloyannis
Jun 19, 2008·Autoimmunity Reviews·Paul SzaboMarc E Weksler

❮ Previous
Next ❯

Citations

Jan 18, 2013·Clinical Reviews in Allergy & Immunology·Assaf MenachemAviva Katzav
Sep 5, 2013·Biochemical Pharmacology·D C Anderson, Krishna Kodukula
Nov 28, 2013·Molecular Diagnosis & Therapy·Ross W PatersonHenrik Zetterberg
Apr 23, 2014·Journal of Proteomics·Diogo Ribeiro DemartiniCélia Regina Carlini
Oct 27, 2014·International Immunology·Andrea MalaspinaSandra Amor
Sep 30, 2015·BioMed Research International·Luiz Carlos de Oliveira-JúniorCarlos Ueira-Vieira
Oct 16, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Scott E CountsElliott J Mufson
Mar 15, 2018·PloS One·Gerd WallukatIngolf Schimke
Sep 8, 2011·Arthritis and Rheumatism·Isabelle Duroux-RichardFlorence Apparailly
Feb 24, 2012·PloS One·Radha DuttaguptaKeith W Jones
Jan 18, 2018·Expert Review of Molecular Diagnostics·Kevin K WangGeoff T Manley
Aug 20, 2015·Proteomics. Clinical Applications·Anna HäggmarkPeter Nilsson
Jul 16, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Kim HenriksenUNKNOWN Blood-Based Biomarker Interest Group
Jul 4, 2018·Journal of Alzheimer's Disease : JAD·Ales BartosJana Švarcová
Mar 14, 2019·World Journal of Gastroenterology : WJG·Aristo Vojdani, Elroy Vojdani
Dec 11, 2014·Annals of Clinical and Translational Neurology·Sarah DossHarald Prüss
Apr 30, 2017·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Libuse NoskovaTomas Zima
Jul 24, 2018·International Journal of Alzheimer's Disease·Aristo Vojdani, Elroy Vojdani
Jun 8, 2018·Frontiers in Medicine·Peilin ZhangRusty Kruzelock
Jan 8, 2021·Metabolic Brain Disease·Jihan AzarAnwar Abdelnaser
Aug 30, 2021·Molecular Neurodegeneration·M Mahafuzur Rahman, Christofer Lendel
Nov 17, 2021·Expert Review of Molecular Diagnostics·Kevin K WangUNKNOWN and the InTBIR Biospecimens/Biomarkers Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.